Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2016. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3708804013 | Product containing bevacizumab in parenteral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3708805014 | Bevacizumab-containing product in parenteral dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4536131000052114 | läkemedel som innehåller bevacizumab, parenteral läkemedelsform | sv | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing bevacizumab in parenteral dose form (medicinal product form) | Is a | Product containing bevacizumab (medicinal product) | true | Inferred relationship | Some | ||
| Product containing bevacizumab in parenteral dose form (medicinal product form) | Is a | Product manufactured as parenteral dose form (product) | true | Inferred relationship | Some | ||
| Product containing bevacizumab in parenteral dose form (medicinal product form) | Has active ingredient | Bevacizumab (substance) | true | Inferred relationship | Some | 1 | |
| Product containing bevacizumab in parenteral dose form (medicinal product form) | Has manufactured dose form | Parenteral dose form (dose form) | true | Inferred relationship | Some | ||
| Product containing bevacizumab in parenteral dose form (medicinal product form) | Plays role | Antineoplastic therapeutic role | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| bevacizumab 25 mg/ml, injektionsvätska, lösning, flaska 4 ml | Is a | False | Product containing bevacizumab in parenteral dose form (medicinal product form) | Inferred relationship | Some | |
| bevacizumab 25 mg/ml, injektionsvätska, lösning, flaska 16 ml | Is a | False | Product containing bevacizumab in parenteral dose form (medicinal product form) | Inferred relationship | Some | |
| bevacizumab 400 mg/16 ml, injektionsvätska, lösning, flaska | Is a | False | Product containing bevacizumab in parenteral dose form (medicinal product form) | Inferred relationship | Some | |
| bevacizumab 100 mg/4 ml, injektionsvätska, lösning, flaska | Is a | False | Product containing bevacizumab in parenteral dose form (medicinal product form) | Inferred relationship | Some | |
| Product containing only bevacizumab in parenteral dose form (medicinal product form) | Is a | True | Product containing bevacizumab in parenteral dose form (medicinal product form) | Inferred relationship | Some |
Reference Sets
Description inactivation indicator reference set
FHIR